Vertex Pharmaceuticals (VRTX) Q4 2022 Earnings Report
0 Followers
MX:VRTX Q4 2022 EPS Results
- Actual EPS
- MXN 69.77
- Consensus EPS
- MXN 65.50
- Beat/Miss
- Beat by +MXN 4.27
- One Year Ago EPS
- MXN 62.53
MX:VRTX Q4 2022 Revenue Results
- Actual Revenue
- MXN 41.76B
- Expected Revenue
- MXN 42.77B
- Beat/Miss
- Missed by -MXN 1.01B
- YoY Revenue Growth
- +9.08%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/07/2023
- Time
- After Close
- Conference Call
- Tuesday, February 7, 2023
MX:VRTX Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
MX:VRTX Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:VRTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | 78.47- | 93.34 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 89.3888.33 | 89.07 | -0.83% (-0.74) | |
| Aug 03, 2026 | 2026 (Q2) | 87.9787.77 | 83.87 | 4.65% (+3.90) | |
| May 04, 2026 | 2026 (Q1) | 78.7382.95 | 75.34 | 10.10% (+7.61) | |
| Feb 12, 2026 | 2025 (Q4) | 94.8493.34 | 73.85 | 26.38% (+19.48) | |
| Nov 03, 2025 | 2025 (Q3) | 84.8689.07 | 81.28 | 9.59% (+7.79) | |
| Aug 06, 2025 | 2025 (Q2) | 79.5783.87 | -238.07 | 135.23% (+321.95) | |
| May 05, 2025 | 2025 (Q1) | 80.1175.34 | 88.33 | -14.71% (-12.99) | |
| Feb 10, 2025 | 2024 (Q4) | 74.5273.85 | 77.94 | -5.24% (-4.08) | |
| Nov 04, 2024 | 2024 (Q3) | 75.6781.28 | 75.71 | 7.35% (+5.57) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
